| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/25/2002 | WO2002057483A2 Method of identifying modulators of nogo-functions |
| 07/25/2002 | WO2002057482A2 Method for differential analysis of bacteria in a sample |
| 07/25/2002 | WO2002057481A2 Repeat-free probes for molecular cytogenetics |
| 07/25/2002 | WO2002057479A2 Primers and methods for the detection and discrimination of nucleic acids |
| 07/25/2002 | WO2002057469A2 Modulating developmental transitions in plants |
| 07/25/2002 | WO2002057465A2 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057451A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | WO2002057427A2 Mammalian tumor susceptibility gene products and their uses |
| 07/25/2002 | WO2002057417A2 Angiogenesis gene and modulators |
| 07/25/2002 | WO2002057415A2 Method for altering cell fate |
| 07/25/2002 | WO2002057414A2 Leukocyte expression profiling |
| 07/25/2002 | WO2002057411A2 Hydrolase enzymes and their use in kinetic resolution |
| 07/25/2002 | WO2002057410A2 Genetic typing of human genes and related materials and methods |
| 07/25/2002 | WO2002057307A2 Genes |
| 07/25/2002 | WO2002057303A2 Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002057297A1 Use of zpr1 as a molecular probe for spinal muscular atrophy |
| 07/25/2002 | WO2002056923A2 Indicator systems for determination of sterilization |
| 07/25/2002 | WO2002056909A2 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids |
| 07/25/2002 | WO2002056893A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 07/25/2002 | WO2002056888A2 Assay method, tnf modulator and its use |
| 07/25/2002 | WO2002056753A2 P27 prevents cellular migration |
| 07/25/2002 | WO2002056670A2 Activatable imaging probes |
| 07/25/2002 | WO2002042410A3 Process for trapping and confining microorganisms in air using water-soluble polymers |
| 07/25/2002 | WO2002038729A3 GENE MONITORING AND GENE IDENTIFICATION USING cDNA ARRAYS |
| 07/25/2002 | WO2002038589A3 Haplotypes of the cyp2d6 gene |
| 07/25/2002 | WO2002036756A3 Lactobacillus strain, and plasmid hosted by same |
| 07/25/2002 | WO2002034935A8 In vitro selection of signaling aptamers |
| 07/25/2002 | WO2002031484A3 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 07/25/2002 | WO2002031120A8 Systems for screening antibacterial and herbicidal compounds |
| 07/25/2002 | WO2002030478A3 Detection of the presence of a microbe or related substance at a location |
| 07/25/2002 | WO2002030256A3 Diagnostic indicator of thymic function |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002018537A3 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002008386A3 Materials and methods for the enhancement of effective root nodulation in legumes |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002004659A3 Relative rates of cytochrome p450 metabolism |
| 07/25/2002 | WO2002003048A8 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001088126A3 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 07/25/2002 | WO2001085340A3 Method for the identification, quantification, and visualisation of micro-organisms |
| 07/25/2002 | WO2001077384A3 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
| 07/25/2002 | WO2001075145A3 Ubiquitin ligase assay |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001066721A3 Nucleic acid sensor molecules |
| 07/25/2002 | WO2001060992A3 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 07/25/2002 | WO2001057256A3 Rolling circle amplification assay for nucleic acid analysis |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001053533A3 Method for cloning polyketide synthase genes |
| 07/25/2002 | WO2001053522A3 (CA)n POLYMORPHISMS IN AN INTRON OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 07/25/2002 | WO2001036442A9 Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay |
| 07/25/2002 | WO2001034201A9 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 07/25/2002 | WO2001032928A3 Methods of determining individual hypersensitivity to an agent |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | WO2001021833A3 Assay for detection of human cftr allele variants using specific diagnostic primers |
| 07/25/2002 | WO2001018250A3 Single nucleotide polymorphisms in genes |
| 07/25/2002 | WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 07/25/2002 | WO2001004613A9 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 07/25/2002 | WO2001004357A9 Generic sbe-fret protocol |
| 07/25/2002 | WO2001002600A9 Detection of analytes using attenuated enzymes |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001002559A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/25/2002 | WO2001001025A9 Microfabricated elastomeric valve and pump systems |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | WO2000056901A9 Linear and circular expression elements |
| 07/25/2002 | US20020100082 Method for determining content of heterologous individual |
| 07/25/2002 | US20020100080 Insecticidal protein for use in biological pest control |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020099202 Compoound for use in the sequencing of nucleic acids |
| 07/25/2002 | US20020099201 Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099019 Used in assaying human pepsin I or human pepsinogen I to diagnose gastric diseases such as gastric cancer and gastric ulcer. |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020098998 P27 prevents cellular migration |
| 07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
| 07/25/2002 | US20020098573 Generating preferential vector nucleotide sequences; obtain nucleotide sequences, incubate with preferential exogenous nucleotide sequences, ligate, recover nucleotide sequences |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098546 Canine TAg1 proteins, nucleic acid molecules, and uses thereof |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098534 Use of selective dna fragment amplification products for hybridization-based genetic fingerprinting, marker assisted selection, and high-throughput screening |
| 07/25/2002 | US20020098533 PKC monocyte assay |
| 07/25/2002 | US20020098531 Rapid methods for microbial typing and enumeration |
| 07/25/2002 | US20020098530 Tumor suppressor gene |
| 07/25/2002 | US20020098526 Apparatus for use in the detection of preferential particles in sample |